EIB
European Investment Bank (EIB) provides lending, borrowing, and treasury services primarily in the European Union. The company offers project loans for the public and private sectors; loans to banks and other intermediaries; structured finance products; guarantees and securitization instruments for senior and subordinated debts; project bonds; equity and fund investment products such as infrastructure equity and debt funds, and environmental funds; and venture capital funds and security packages for funds. The company also offers microfinance; risk sharing finance for research, development, and innovation projects; finance and technical expertise for sustainable energy projects; infrastructure project advisory services; support for urban development projects; guarantees for transport infrastructure; and funding for public-private partnerships and small- and medium-sized enterprises. EIB serves the transportation, global loans, energy, industry, health, education, water, sewerage, infrastructure, services, telecommunications, agriculture, and fisheries sectors. European Investment Bank was founded in 1958 and is based in Luxembourg.
Power Capital Renewable Energy specialize in developing large scale photovoltaic solar farms. The company began by acquiring and asset managing utility scale solar parks.
Ovagen is a biotechnology company that has developed the process of producing germ free (GF) chicken eggs and GF birds in commercial quantities for use primarily in the pharmaceutical industry. Ovagen can also provide a Contract Research Service and has extensive expertise in SPF poultry & rodent housing & husbandry, in specific poultry & rodent research technologies to GMP standards and in avian transgenics.
Loci Orthopaedics Limited manufactures medical and dental instruments. The company provides surgical implant for patients with arthritis in their thumb base joint. The company was incorporated in 2017 and is based in Upper Newcastle. Ireland.
Priothera Ltd is a clinical-stage company focused on developing orally administered sphingosine 1 phosphate (S1P) receptor modulators aimed at treating haematological malignancies. Founded in 2020 and based in Dublin, Ireland, with an additional location in Saint Louis, France, the company seeks to improve patient outcomes by enhancing the curative potential of allogeneic hematopoietic stem cell transplantation. Its lead product, mocravimod, is designed to reduce the egress of specific T cell subsets from lymphatic tissues, thereby providing dual inhibition of graft versus host disease while promoting graft versus leukemia effects. Through this innovative approach, Priothera aims to deliver significant advancements in the treatment of patients with blood cancers.
Founded in 1854, University College Dublin is a non-profit organisation based in Ireland. The foundation is an educational institution which offers graduate and undergraduate programs in accounting, biology and others streams.
Provider of broadband services. The company operates a fiber-to-the-building broadband network offering speeds from 200 Mbps to 1000 Mbps.
ESB International (ESBI) is a growing international energy company and one of Europe's leading engineering and consultancy organisations. They are responsible for the non-regulated businesses in ESB and operate across a wide area of the energy industry. They also provide engineering design, construction management and strategic consultancy services to clients in Ireland and to the power sector worldwide.
Carbery Group is recognised as an international manufacturer of speciality food ingredients, flavouring systems and as an award-winning cheese producer. We are owned by four Irish dairy co-operatives, employ more than 600 people, and manufacture from 8 facilities worldwide, including Ireland, UK, USA, Brazil and Thailand.
Vivasure Medical Limited is a medical device company based in Galway, Ireland, focused on the research, development, and manufacturing of arterial and venous closure devices utilizing its proprietary PerQseal technology. The company specializes in creating polymer implants and delivery systems aimed at facilitating minimally invasive vessel closures in cardiology, interventional radiology, and vascular surgery. Its flagship product is an absorbable patch-based large-bore percutaneous closure device, specifically designed to close large arteriotomies during transcatheter procedures like transcatheter aortic valve replacement and endovascular aneurysm repair. Established in 2008, Vivasure Medical aims to enhance patient outcomes in vascular access procedures through innovative medical solutions.
Cubic Telecom is a global connectivity platform company offering solutions for leading Internet of things (IoT), machine-to-machine (M2M), and device manufacturing companies across the globe.
As a proud member of the GSMA, we provide connectivity in over 100 countries, boasting the most robust network, device and retail partnerships worldwide. With our flexible over-the-air (OTA) device management, we are experts in enabling global scalability with local connectivity anytime, anywhere.
Our partners and customers include some of the world’s leading Fortune 100 tablet and notebook manufacturers, retailers, and M2M and automotive companies. Our clients believe in our work. They include Audi, Lenovo, HP, Rakuten, and Woolworths.
Full Investment Portfolio:
Bonds: 4.74%
Equities: 69.45%
Property: 16.42%
Infrastructure/Other: 9.39%
Founded in 1592, Trinity College Dublin is a non-profit organisation based in Ireland. The foundation is an educational institution that provides degrees in undergraduate and graduate levels in art, media, music, business, education and science.
Aerogen Limited, a medical device and drug delivery company, engages in the design, manufacture, and marketing of aerosol drug delivery systems. It offers Aerogen Solo, a compact and single patient use nebulizer for aerosol therapy; Aerogen Ultra, a solution for spontaneous breathing patients; Aerogen Pro, a nebulizer for treating mechanically ventilated patients; Aerogen Go, a nebulizer enabling people to build their nebulizer treatments; Aerogen Lab, a nebulizer for use in preclinical aerosol research and inhalation studies; Aerogen Pro-X Controller, portable power source for Aerogen Solo; Aerogen USB controller, power source for Aerogen Solo; Aerogen nebulization, a tube set for continuous nebulization and precise medication control of patients, and Vibronic, a high performance aerosol technology. The company sells its products through a network of distributors worldwide. Aerogen Limited was formerly known as Aerogen (Ireland) Ltd. and changed its name to Aerogen Limited in December 2007. The company was founded in 1997 and is based in Galway, Ireland with additional offices in Chicago, Illinois; Ratingen, Germany; Fengtai District, China; Dubai, United Arab Emirates; and New Delhi, Delhi.
Nuritas is revolutionising the discovery of novel, natural and scientifically proven active ingredients that can manage and improve human health. The company’s disruptive computational approach to discovery uses artificial intelligence and genomics to, for the first time ever, rapidly and efficiently predict and then provide access to the most health-benefiting components hidden within food, called bioactive peptides.
Full Investment Portfolio:
Bonds: 4.74%
Equities: 69.45%
Property: 16.42%
Infrastructure/Other: 9.39%
Founded in 1592, Trinity College Dublin is a non-profit organisation based in Ireland. The foundation is an educational institution that provides degrees in undergraduate and graduate levels in art, media, music, business, education and science.
M-BIRR Limited is a provider of mobile banking services based in Dublin, Ireland, offering a comprehensive platform for mobile money transactions in Ethiopia. Established in 2001, M-BIRR facilitates a range of financial services, including domestic money transfers, balance inquiries, loan repayments, cash in/out through an extensive agent network, and international remittances. Users can conveniently pay for goods and services directly from their mobile phones, eliminating the need for time-consuming travel and queuing. The platform also enables utility bill payments and supports businesses with marketing and strategy consulting. M-BIRR is designed to cater to both residential and business customers, as well as banks and microfinance institutions, ensuring efficient and reliable financial transactions available around the clock.
Amryt Pharma is a biopharmaceutical company dedicated to developing and commercializing innovative therapeutics for patients with serious and life-threatening rare diseases. The company offers several commercial products, including Myalept/Myalepta, which addresses complications related to leptin deficiency in patients with generalized lipodystrophy, and Lojuxta/Juxtapid, used to manage cholesterol levels in adults with homozygous familial hypercholesterolemia. Amryt Pharma is also advancing its development candidates, including FILSUVEZ, aimed at treating the cutaneous manifestations of epidermolysis bullosa, and AP103, a pre-clinical gene therapy platform for recessive dystrophic epidermolysis bullosa. Founded in 2015 and based in London, the company sells its products across the Americas, Europe, and the Middle East. Amryt is also exploring novel treatments for rare neuroendocrine diseases, focusing on unmet medical needs in conditions like acromegaly and Cushing's disease.
DCU is a young, dynamic and ambitious university with a distinctive mission to transform lives and societies through education, research and innovation. Since admitting its first students in 1980, DCU has grown in both student numbers and size and now occupies a 72 acre site in Glasnevin, just north of Dublin city.
Innovation Ulster Limited (IUL) is a knowledge and technology venturing company wholly owned by Ulster University. Its primary focus is to support the commercial development of the university's research, facilitating the transfer of valuable inventions and knowledge to the private sector. IUL aims to foster an entrepreneurial environment within the university, encouraging both staff and students to generate new inventions and educational materials. The company seeks to enhance the commercial impact of Ulster's research while ensuring that the long-term financial returns on its investments meet or exceed spending rates, all within an acceptable risk framework. Through these efforts, IUL promotes the attractiveness of Ulster's intellectual property, ultimately contributing to societal and economic advancement.